nodes	percent_of_prediction	percent_of_DWPC	metapath
Digoxin—SLCO4C1—Methotrexate—systemic scleroderma	0.135	0.172	CbGbCtD
Digoxin—SLCO1B3—Mycophenolate mofetil—systemic scleroderma	0.132	0.168	CbGbCtD
Digoxin—SLCO1C1—Methotrexate—systemic scleroderma	0.095	0.121	CbGbCtD
Digoxin—SLCO1B1—Mycophenolate mofetil—systemic scleroderma	0.077	0.0978	CbGbCtD
Digoxin—SLCO1A2—Prednisone—systemic scleroderma	0.0653	0.0829	CbGbCtD
Digoxin—SLCO1B3—Methotrexate—systemic scleroderma	0.0531	0.0673	CbGbCtD
Digoxin—ABCB1—Lisinopril—systemic scleroderma	0.0374	0.0475	CbGbCtD
Digoxin—SLCO1A2—Methotrexate—systemic scleroderma	0.0327	0.0416	CbGbCtD
Digoxin—SLCO1B1—Methotrexate—systemic scleroderma	0.0309	0.0392	CbGbCtD
Digoxin—SLC22A8—Methotrexate—systemic scleroderma	0.0285	0.0362	CbGbCtD
Digoxin—ABCB1—Captopril—systemic scleroderma	0.028	0.0356	CbGbCtD
Digoxin—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0221	0.028	CbGbCtD
Digoxin—ABCB1—Prednisone—systemic scleroderma	0.0176	0.0224	CbGbCtD
Digoxin—Atrial tachycardia—Lisinopril—systemic scleroderma	0.0151	0.098	CcSEcCtD
Digoxin—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0132	0.0168	CbGbCtD
Digoxin—CYP3A4—Prednisone—systemic scleroderma	0.0106	0.0134	CbGbCtD
Digoxin—ABCB1—Methotrexate—systemic scleroderma	0.00885	0.0112	CbGbCtD
Digoxin—Toxicity to various agents—Mycophenolic acid—systemic scleroderma	0.00488	0.0317	CcSEcCtD
Digoxin—Atrioventricular block complete—Lisinopril—systemic scleroderma	0.00359	0.0234	CcSEcCtD
Digoxin—SLC51B—digestive system—systemic scleroderma	0.00337	0.0577	CbGeAlD
Digoxin—SLC51B—tendon—systemic scleroderma	0.00321	0.0549	CbGeAlD
Digoxin—SLC51B—lung—systemic scleroderma	0.00281	0.0482	CbGeAlD
Digoxin—ATP1B3—skin of body—systemic scleroderma	0.00264	0.0453	CbGeAlD
Digoxin—SLC51A—digestive system—systemic scleroderma	0.00241	0.0413	CbGeAlD
Digoxin—SLC51A—tendon—systemic scleroderma	0.0023	0.0393	CbGeAlD
Digoxin—Necrosis—Captopril—systemic scleroderma	0.00226	0.0147	CcSEcCtD
Digoxin—FXYD2—tendon—systemic scleroderma	0.00221	0.0378	CbGeAlD
Digoxin—Digestion impaired—Leflunomide—systemic scleroderma	0.00219	0.0142	CcSEcCtD
Digoxin—ATP1B3—digestive system—systemic scleroderma	0.00212	0.0362	CbGeAlD
Digoxin—SLC51A—lung—systemic scleroderma	0.00202	0.0345	CbGeAlD
Digoxin—Apathy—Mycophenolic acid—systemic scleroderma	0.00195	0.0127	CcSEcCtD
Digoxin—FXYD2—lung—systemic scleroderma	0.00194	0.0332	CbGeAlD
Digoxin—Flat affect—Mycophenolic acid—systemic scleroderma	0.00193	0.0126	CcSEcCtD
Digoxin—Drug interaction—Captopril—systemic scleroderma	0.00191	0.0124	CcSEcCtD
Digoxin—ATP1B3—lung—systemic scleroderma	0.00177	0.0303	CbGeAlD
Digoxin—ATP1B2—tendon—systemic scleroderma	0.00176	0.0301	CbGeAlD
Digoxin—CYP11A1—connective tissue—systemic scleroderma	0.00176	0.0301	CbGeAlD
Digoxin—ATP1A2—tendon—systemic scleroderma	0.00171	0.0293	CbGeAlD
Digoxin—Extrasystoles—Mycophenolic acid—systemic scleroderma	0.00166	0.0108	CcSEcCtD
Digoxin—Ventricular fibrillation—Lisinopril—systemic scleroderma	0.00164	0.0107	CcSEcCtD
Digoxin—Delirium—Mycophenolic acid—systemic scleroderma	0.00162	0.0105	CcSEcCtD
Digoxin—Gynaecomastia—Captopril—systemic scleroderma	0.00159	0.0103	CcSEcCtD
Digoxin—ATP1B1—digestive system—systemic scleroderma	0.00156	0.0268	CbGeAlD
Digoxin—ABCB11—digestive system—systemic scleroderma	0.00155	0.0265	CbGeAlD
Digoxin—Ventricular extrasystoles—Mycophenolic acid—systemic scleroderma	0.00154	0.01	CcSEcCtD
Digoxin—ATP1B2—lung—systemic scleroderma	0.00154	0.0264	CbGeAlD
Digoxin—SLCO4C1—lung—systemic scleroderma	0.00154	0.0264	CbGeAlD
Digoxin—Apathy—Mycophenolate mofetil—systemic scleroderma	0.00154	0.01	CcSEcCtD
Digoxin—Flat affect—Mycophenolate mofetil—systemic scleroderma	0.00153	0.00993	CcSEcCtD
Digoxin—ATP1A2—lung—systemic scleroderma	0.0015	0.0257	CbGeAlD
Digoxin—SLCO1B3—lung—systemic scleroderma	0.0015	0.0257	CbGeAlD
Digoxin—ATP1B1—tendon—systemic scleroderma	0.00149	0.0255	CbGeAlD
Digoxin—Ventricular tachycardia—Mycophenolic acid—systemic scleroderma	0.00139	0.00907	CcSEcCtD
Digoxin—Ventricular extrasystoles—Lisinopril—systemic scleroderma	0.00139	0.00904	CcSEcCtD
Digoxin—Drug interaction—Lisinopril—systemic scleroderma	0.00135	0.0088	CcSEcCtD
Digoxin—Rash maculo-papular—Leflunomide—systemic scleroderma	0.00133	0.00864	CcSEcCtD
Digoxin—Extrasystoles—Mycophenolate mofetil—systemic scleroderma	0.00131	0.0085	CcSEcCtD
Digoxin—ATP1B1—lung—systemic scleroderma	0.00131	0.0224	CbGeAlD
Digoxin—Delirium—Mycophenolate mofetil—systemic scleroderma	0.00128	0.00832	CcSEcCtD
Digoxin—Ventricular tachycardia—Lisinopril—systemic scleroderma	0.00126	0.00817	CcSEcCtD
Digoxin—Cardiac arrest—Captopril—systemic scleroderma	0.00122	0.00796	CcSEcCtD
Digoxin—Ventricular extrasystoles—Mycophenolate mofetil—systemic scleroderma	0.00122	0.00792	CcSEcCtD
Digoxin—SLCO4A1—digestive system—systemic scleroderma	0.00118	0.0202	CbGeAlD
Digoxin—ATP1A1—connective tissue—systemic scleroderma	0.00112	0.0192	CbGeAlD
Digoxin—Ventricular tachycardia—Mycophenolate mofetil—systemic scleroderma	0.0011	0.00716	CcSEcCtD
Digoxin—Arrhythmia—Pentoxifylline—systemic scleroderma	0.00105	0.00683	CcSEcCtD
Digoxin—SLCO1B1—digestive system—systemic scleroderma	0.00104	0.0178	CbGeAlD
Digoxin—ATP1A1—smooth muscle tissue—systemic scleroderma	0.00102	0.0175	CbGeAlD
Digoxin—ATP1A1—skin of body—systemic scleroderma	0.00101	0.0173	CbGeAlD
Digoxin—Rash maculo-papular—Mycophenolate mofetil—systemic scleroderma	0.001	0.0065	CcSEcCtD
Digoxin—Psychotic disorder—Mycophenolic acid—systemic scleroderma	0.000988	0.00643	CcSEcCtD
Digoxin—SLCO4A1—lung—systemic scleroderma	0.000985	0.0169	CbGeAlD
Digoxin—Gynaecomastia—Mycophenolate mofetil—systemic scleroderma	0.000984	0.0064	CcSEcCtD
Digoxin—Vision blurred—Pentoxifylline—systemic scleroderma	0.000964	0.00627	CcSEcCtD
Digoxin—Cardiac arrest—Mycophenolic acid—systemic scleroderma	0.000962	0.00626	CcSEcCtD
Digoxin—Necrosis—Prednisone—systemic scleroderma	0.00095	0.00618	CcSEcCtD
Digoxin—SLCO2B1—digestive system—systemic scleroderma	0.000917	0.0157	CbGeAlD
Digoxin—Palpitations—Pentoxifylline—systemic scleroderma	0.000904	0.00588	CcSEcCtD
Digoxin—Hallucination—Captopril—systemic scleroderma	0.000886	0.00576	CcSEcCtD
Digoxin—SLCO2B1—tendon—systemic scleroderma	0.000873	0.015	CbGeAlD
Digoxin—Anxiety—Pentoxifylline—systemic scleroderma	0.000867	0.00564	CcSEcCtD
Digoxin—Delirium—Prednisone—systemic scleroderma	0.000867	0.00564	CcSEcCtD
Digoxin—Cardiac arrest—Lisinopril—systemic scleroderma	0.000866	0.00564	CcSEcCtD
Digoxin—SLCO1A2—digestive system—systemic scleroderma	0.000844	0.0145	CbGeAlD
Digoxin—Visual disturbance—Mycophenolate mofetil—systemic scleroderma	0.000842	0.00548	CcSEcCtD
Digoxin—Confusional state—Pentoxifylline—systemic scleroderma	0.000841	0.00547	CcSEcCtD
Digoxin—Thrombocytopenia—Pentoxifylline—systemic scleroderma	0.000817	0.00532	CcSEcCtD
Digoxin—Tachycardia—Pentoxifylline—systemic scleroderma	0.000814	0.0053	CcSEcCtD
Digoxin—ATP1A1—digestive system—systemic scleroderma	0.000808	0.0138	CbGeAlD
Digoxin—Anorexia—Pentoxifylline—systemic scleroderma	0.000795	0.00518	CcSEcCtD
Digoxin—Necrosis—Methotrexate—systemic scleroderma	0.000794	0.00516	CcSEcCtD
Digoxin—Psychotic disorder—Mycophenolate mofetil—systemic scleroderma	0.00078	0.00507	CcSEcCtD
Digoxin—ATP1A1—tendon—systemic scleroderma	0.000769	0.0132	CbGeAlD
Digoxin—SLCO2B1—lung—systemic scleroderma	0.000766	0.0131	CbGeAlD
Digoxin—ABCB1—blood vessel—systemic scleroderma	0.000764	0.0131	CbGeAlD
Digoxin—Cardiac arrest—Mycophenolate mofetil—systemic scleroderma	0.000759	0.00494	CcSEcCtD
Digoxin—Dyspepsia—Pentoxifylline—systemic scleroderma	0.000735	0.00478	CcSEcCtD
Digoxin—Vision blurred—Captopril—systemic scleroderma	0.00073	0.00475	CcSEcCtD
Digoxin—Decreased appetite—Pentoxifylline—systemic scleroderma	0.000725	0.00472	CcSEcCtD
Digoxin—SLCO1A2—lung—systemic scleroderma	0.000705	0.0121	CbGeAlD
Digoxin—Hallucination—Mycophenolic acid—systemic scleroderma	0.000696	0.00453	CcSEcCtD
Digoxin—Arrhythmia—Azathioprine—systemic scleroderma	0.000694	0.00452	CcSEcCtD
Digoxin—Feeling abnormal—Pentoxifylline—systemic scleroderma	0.000688	0.00447	CcSEcCtD
Digoxin—Anorexia—Mometasone—systemic scleroderma	0.000686	0.00447	CcSEcCtD
Digoxin—Palpitations—Captopril—systemic scleroderma	0.000685	0.00446	CcSEcCtD
Digoxin—Gastrointestinal pain—Pentoxifylline—systemic scleroderma	0.000682	0.00444	CcSEcCtD
Digoxin—Cardiac disorder—Leflunomide—systemic scleroderma	0.000681	0.00443	CcSEcCtD
Digoxin—ATP1A1—lung—systemic scleroderma	0.000675	0.0116	CbGeAlD
Digoxin—Visual impairment—Mycophenolic acid—systemic scleroderma	0.000674	0.00439	CcSEcCtD
Digoxin—Abdominal pain—Pentoxifylline—systemic scleroderma	0.00066	0.00429	CcSEcCtD
Digoxin—Arrhythmia—Leflunomide—systemic scleroderma	0.000655	0.00426	CcSEcCtD
Digoxin—Cardiac disorder—Mycophenolic acid—systemic scleroderma	0.00065	0.00423	CcSEcCtD
Digoxin—Confusional state—Captopril—systemic scleroderma	0.000638	0.00415	CcSEcCtD
Digoxin—Dyspepsia—Mometasone—systemic scleroderma	0.000634	0.00412	CcSEcCtD
Digoxin—Hallucination—Lisinopril—systemic scleroderma	0.000627	0.00408	CcSEcCtD
Digoxin—Decreased appetite—Mometasone—systemic scleroderma	0.000626	0.00407	CcSEcCtD
Digoxin—Arrhythmia—Mycophenolic acid—systemic scleroderma	0.000625	0.00407	CcSEcCtD
Digoxin—Thrombocytopenia—Captopril—systemic scleroderma	0.000619	0.00403	CcSEcCtD
Digoxin—Tachycardia—Captopril—systemic scleroderma	0.000617	0.00402	CcSEcCtD
Digoxin—Anorexia—Captopril—systemic scleroderma	0.000603	0.00392	CcSEcCtD
Digoxin—Vision blurred—Leflunomide—systemic scleroderma	0.000602	0.00392	CcSEcCtD
Digoxin—Asthenia—Pentoxifylline—systemic scleroderma	0.000599	0.0039	CcSEcCtD
Digoxin—Gastrointestinal pain—Mometasone—systemic scleroderma	0.000589	0.00383	CcSEcCtD
Digoxin—Vision blurred—Mycophenolic acid—systemic scleroderma	0.000574	0.00374	CcSEcCtD
Digoxin—Diarrhoea—Pentoxifylline—systemic scleroderma	0.000571	0.00371	CcSEcCtD
Digoxin—Abdominal pain—Mometasone—systemic scleroderma	0.000569	0.0037	CcSEcCtD
Digoxin—Palpitations—Leflunomide—systemic scleroderma	0.000564	0.00367	CcSEcCtD
Digoxin—Arrhythmia—Lisinopril—systemic scleroderma	0.000563	0.00366	CcSEcCtD
Digoxin—Gynaecomastia—Methotrexate—systemic scleroderma	0.000557	0.00363	CcSEcCtD
Digoxin—Dyspepsia—Captopril—systemic scleroderma	0.000557	0.00362	CcSEcCtD
Digoxin—Dizziness—Pentoxifylline—systemic scleroderma	0.000552	0.00359	CcSEcCtD
Digoxin—Decreased appetite—Captopril—systemic scleroderma	0.00055	0.00358	CcSEcCtD
Digoxin—Hallucination—Mycophenolate mofetil—systemic scleroderma	0.00055	0.00358	CcSEcCtD
Digoxin—Anxiety—Leflunomide—systemic scleroderma	0.000542	0.00353	CcSEcCtD
Digoxin—Thrombocytopenia—Azathioprine—systemic scleroderma	0.00054	0.00352	CcSEcCtD
Digoxin—Palpitations—Mycophenolic acid—systemic scleroderma	0.000538	0.0035	CcSEcCtD
Digoxin—Visual impairment—Mycophenolate mofetil—systemic scleroderma	0.000532	0.00346	CcSEcCtD
Digoxin—Vomiting—Pentoxifylline—systemic scleroderma	0.000531	0.00345	CcSEcCtD
Digoxin—Psychotic disorder—Prednisone—systemic scleroderma	0.000529	0.00344	CcSEcCtD
Digoxin—Rash—Pentoxifylline—systemic scleroderma	0.000526	0.00342	CcSEcCtD
Digoxin—Dermatitis—Pentoxifylline—systemic scleroderma	0.000526	0.00342	CcSEcCtD
Digoxin—Headache—Pentoxifylline—systemic scleroderma	0.000523	0.0034	CcSEcCtD
Digoxin—Feeling abnormal—Captopril—systemic scleroderma	0.000521	0.00339	CcSEcCtD
Digoxin—Vision blurred—Lisinopril—systemic scleroderma	0.000517	0.00336	CcSEcCtD
Digoxin—Gastrointestinal pain—Captopril—systemic scleroderma	0.000517	0.00336	CcSEcCtD
Digoxin—Anxiety—Mycophenolic acid—systemic scleroderma	0.000517	0.00336	CcSEcCtD
Digoxin—Asthenia—Mometasone—systemic scleroderma	0.000517	0.00336	CcSEcCtD
Digoxin—Cardiac arrest—Prednisone—systemic scleroderma	0.000515	0.00335	CcSEcCtD
Digoxin—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	0.000513	0.00334	CcSEcCtD
Digoxin—Thrombocytopenia—Leflunomide—systemic scleroderma	0.00051	0.00332	CcSEcCtD
Digoxin—Tachycardia—Leflunomide—systemic scleroderma	0.000509	0.00331	CcSEcCtD
Digoxin—Confusional state—Mycophenolic acid—systemic scleroderma	0.000501	0.00326	CcSEcCtD
Digoxin—Abdominal pain—Captopril—systemic scleroderma	0.0005	0.00325	CcSEcCtD
Digoxin—Anorexia—Leflunomide—systemic scleroderma	0.000497	0.00323	CcSEcCtD
Digoxin—Nausea—Pentoxifylline—systemic scleroderma	0.000496	0.00322	CcSEcCtD
Digoxin—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.000493	0.00321	CcSEcCtD
Digoxin—Diarrhoea—Mometasone—systemic scleroderma	0.000493	0.00321	CcSEcCtD
Digoxin—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000487	0.00317	CcSEcCtD
Digoxin—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000485	0.00316	CcSEcCtD
Digoxin—Palpitations—Lisinopril—systemic scleroderma	0.000485	0.00316	CcSEcCtD
Digoxin—Visual disturbance—Methotrexate—systemic scleroderma	0.000477	0.00311	CcSEcCtD
Digoxin—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000476	0.0031	CcSEcCtD
Digoxin—Anorexia—Mycophenolic acid—systemic scleroderma	0.000474	0.00308	CcSEcCtD
Digoxin—Anxiety—Lisinopril—systemic scleroderma	0.000466	0.00303	CcSEcCtD
Digoxin—Dyspepsia—Leflunomide—systemic scleroderma	0.000459	0.00298	CcSEcCtD
Digoxin—Vomiting—Mometasone—systemic scleroderma	0.000458	0.00298	CcSEcCtD
Digoxin—Feeling abnormal—Azathioprine—systemic scleroderma	0.000455	0.00296	CcSEcCtD
Digoxin—Rash—Mometasone—systemic scleroderma	0.000454	0.00295	CcSEcCtD
Digoxin—Asthenia—Captopril—systemic scleroderma	0.000454	0.00295	CcSEcCtD
Digoxin—Dermatitis—Mometasone—systemic scleroderma	0.000454	0.00295	CcSEcCtD
Digoxin—Decreased appetite—Leflunomide—systemic scleroderma	0.000453	0.00295	CcSEcCtD
Digoxin—Confusional state—Lisinopril—systemic scleroderma	0.000452	0.00294	CcSEcCtD
Digoxin—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000451	0.00294	CcSEcCtD
Digoxin—Headache—Mometasone—systemic scleroderma	0.000451	0.00293	CcSEcCtD
Digoxin—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00045	0.00293	CcSEcCtD
Digoxin—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000438	0.00285	CcSEcCtD
Digoxin—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000438	0.00285	CcSEcCtD
Digoxin—Tachycardia—Lisinopril—systemic scleroderma	0.000437	0.00284	CcSEcCtD
Digoxin—Abdominal pain—Azathioprine—systemic scleroderma	0.000436	0.00284	CcSEcCtD
Digoxin—Diarrhoea—Captopril—systemic scleroderma	0.000433	0.00282	CcSEcCtD
Digoxin—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000432	0.00281	CcSEcCtD
Digoxin—Feeling abnormal—Leflunomide—systemic scleroderma	0.00043	0.00279	CcSEcCtD
Digoxin—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000429	0.00279	CcSEcCtD
Digoxin—Nausea—Mometasone—systemic scleroderma	0.000428	0.00278	CcSEcCtD
Digoxin—Anorexia—Lisinopril—systemic scleroderma	0.000427	0.00278	CcSEcCtD
Digoxin—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000426	0.00277	CcSEcCtD
Digoxin—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000425	0.00276	CcSEcCtD
Digoxin—Dizziness—Captopril—systemic scleroderma	0.000418	0.00272	CcSEcCtD
Digoxin—Abdominal pain—Leflunomide—systemic scleroderma	0.000412	0.00268	CcSEcCtD
Digoxin—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00041	0.00267	CcSEcCtD
Digoxin—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000408	0.00265	CcSEcCtD
Digoxin—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000407	0.00265	CcSEcCtD
Digoxin—Vomiting—Captopril—systemic scleroderma	0.000402	0.00262	CcSEcCtD
Digoxin—CYP3A4—digestive system—systemic scleroderma	0.0004	0.00684	CbGeAlD
Digoxin—Rash—Captopril—systemic scleroderma	0.000399	0.00259	CcSEcCtD
Digoxin—Dermatitis—Captopril—systemic scleroderma	0.000398	0.00259	CcSEcCtD
Digoxin—Headache—Captopril—systemic scleroderma	0.000396	0.00258	CcSEcCtD
Digoxin—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000396	0.00257	CcSEcCtD
Digoxin—Dyspepsia—Lisinopril—systemic scleroderma	0.000394	0.00256	CcSEcCtD
Digoxin—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000393	0.00256	CcSEcCtD
Digoxin—Decreased appetite—Lisinopril—systemic scleroderma	0.000389	0.00253	CcSEcCtD
Digoxin—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000387	0.00252	CcSEcCtD
Digoxin—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000384	0.0025	CcSEcCtD
Digoxin—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000383	0.00249	CcSEcCtD
Digoxin—Diarrhoea—Azathioprine—systemic scleroderma	0.000378	0.00246	CcSEcCtD
Digoxin—Nausea—Captopril—systemic scleroderma	0.000376	0.00244	CcSEcCtD
Digoxin—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000374	0.00243	CcSEcCtD
Digoxin—Asthenia—Leflunomide—systemic scleroderma	0.000374	0.00243	CcSEcCtD
Digoxin—Hallucination—Prednisone—systemic scleroderma	0.000373	0.00242	CcSEcCtD
Digoxin—Feeling abnormal—Lisinopril—systemic scleroderma	0.000369	0.0024	CcSEcCtD
Digoxin—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000366	0.00238	CcSEcCtD
Digoxin—Dizziness—Azathioprine—systemic scleroderma	0.000365	0.00237	CcSEcCtD
Digoxin—Asthenia—Mycophenolic acid—systemic scleroderma	0.000357	0.00232	CcSEcCtD
Digoxin—Diarrhoea—Leflunomide—systemic scleroderma	0.000357	0.00232	CcSEcCtD
Digoxin—Abdominal pain—Lisinopril—systemic scleroderma	0.000354	0.0023	CcSEcCtD
Digoxin—Vomiting—Azathioprine—systemic scleroderma	0.000351	0.00228	CcSEcCtD
Digoxin—Rash—Azathioprine—systemic scleroderma	0.000348	0.00226	CcSEcCtD
Digoxin—Dermatitis—Azathioprine—systemic scleroderma	0.000348	0.00226	CcSEcCtD
Digoxin—Headache—Azathioprine—systemic scleroderma	0.000346	0.00225	CcSEcCtD
Digoxin—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000345	0.00225	CcSEcCtD
Digoxin—Dizziness—Leflunomide—systemic scleroderma	0.000345	0.00224	CcSEcCtD
Digoxin—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000341	0.00222	CcSEcCtD
Digoxin—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00034	0.00221	CcSEcCtD
Digoxin—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000339	0.0022	CcSEcCtD
Digoxin—Arrhythmia—Prednisone—systemic scleroderma	0.000334	0.00218	CcSEcCtD
Digoxin—Vomiting—Leflunomide—systemic scleroderma	0.000331	0.00216	CcSEcCtD
Digoxin—Dizziness—Mycophenolic acid—systemic scleroderma	0.000329	0.00214	CcSEcCtD
Digoxin—Rash—Leflunomide—systemic scleroderma	0.000329	0.00214	CcSEcCtD
Digoxin—Dermatitis—Leflunomide—systemic scleroderma	0.000328	0.00214	CcSEcCtD
Digoxin—Nausea—Azathioprine—systemic scleroderma	0.000328	0.00213	CcSEcCtD
Digoxin—Headache—Leflunomide—systemic scleroderma	0.000327	0.00212	CcSEcCtD
Digoxin—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000323	0.0021	CcSEcCtD
Digoxin—Asthenia—Lisinopril—systemic scleroderma	0.000321	0.00209	CcSEcCtD
Digoxin—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000321	0.00209	CcSEcCtD
Digoxin—Vomiting—Mycophenolic acid—systemic scleroderma	0.000316	0.00206	CcSEcCtD
Digoxin—Rash—Mycophenolic acid—systemic scleroderma	0.000314	0.00204	CcSEcCtD
Digoxin—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000313	0.00204	CcSEcCtD
Digoxin—Headache—Mycophenolic acid—systemic scleroderma	0.000311	0.00203	CcSEcCtD
Digoxin—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00031	0.00202	CcSEcCtD
Digoxin—Nausea—Leflunomide—systemic scleroderma	0.00031	0.00201	CcSEcCtD
Digoxin—Vision blurred—Prednisone—systemic scleroderma	0.000307	0.002	CcSEcCtD
Digoxin—Diarrhoea—Lisinopril—systemic scleroderma	0.000306	0.00199	CcSEcCtD
Digoxin—Visual impairment—Methotrexate—systemic scleroderma	0.000302	0.00196	CcSEcCtD
Digoxin—Dizziness—Lisinopril—systemic scleroderma	0.000296	0.00193	CcSEcCtD
Digoxin—Nausea—Mycophenolic acid—systemic scleroderma	0.000295	0.00192	CcSEcCtD
Digoxin—Cardiac disorder—Methotrexate—systemic scleroderma	0.00029	0.00189	CcSEcCtD
Digoxin—Vomiting—Lisinopril—systemic scleroderma	0.000285	0.00185	CcSEcCtD
Digoxin—ABCB1—digestive system—systemic scleroderma	0.000283	0.00484	CbGeAlD
Digoxin—Rash—Lisinopril—systemic scleroderma	0.000282	0.00184	CcSEcCtD
Digoxin—Dermatitis—Lisinopril—systemic scleroderma	0.000282	0.00184	CcSEcCtD
Digoxin—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000282	0.00183	CcSEcCtD
Digoxin—Headache—Lisinopril—systemic scleroderma	0.000281	0.00183	CcSEcCtD
Digoxin—Anxiety—Prednisone—systemic scleroderma	0.000277	0.0018	CcSEcCtD
Digoxin—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000268	0.00175	CcSEcCtD
Digoxin—Nausea—Lisinopril—systemic scleroderma	0.000266	0.00173	CcSEcCtD
Digoxin—Tachycardia—Prednisone—systemic scleroderma	0.00026	0.00169	CcSEcCtD
Digoxin—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000259	0.00169	CcSEcCtD
Digoxin—Vision blurred—Methotrexate—systemic scleroderma	0.000257	0.00167	CcSEcCtD
Digoxin—Anorexia—Prednisone—systemic scleroderma	0.000254	0.00165	CcSEcCtD
Digoxin—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000249	0.00162	CcSEcCtD
Digoxin—Rash—Mycophenolate mofetil—systemic scleroderma	0.000247	0.00161	CcSEcCtD
Digoxin—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000247	0.00161	CcSEcCtD
Digoxin—Headache—Mycophenolate mofetil—systemic scleroderma	0.000246	0.0016	CcSEcCtD
Digoxin—ABCB1—lung—systemic scleroderma	0.000236	0.00404	CbGeAlD
Digoxin—Dyspepsia—Prednisone—systemic scleroderma	0.000234	0.00152	CcSEcCtD
Digoxin—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000233	0.00152	CcSEcCtD
Digoxin—Decreased appetite—Prednisone—systemic scleroderma	0.000231	0.0015	CcSEcCtD
Digoxin—Confusional state—Methotrexate—systemic scleroderma	0.000224	0.00146	CcSEcCtD
Digoxin—Feeling abnormal—Prednisone—systemic scleroderma	0.000219	0.00143	CcSEcCtD
Digoxin—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000218	0.00142	CcSEcCtD
Digoxin—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000218	0.00142	CcSEcCtD
Digoxin—Anorexia—Methotrexate—systemic scleroderma	0.000212	0.00138	CcSEcCtD
Digoxin—Abdominal pain—Prednisone—systemic scleroderma	0.00021	0.00137	CcSEcCtD
Digoxin—Dyspepsia—Methotrexate—systemic scleroderma	0.000196	0.00127	CcSEcCtD
Digoxin—Decreased appetite—Methotrexate—systemic scleroderma	0.000193	0.00126	CcSEcCtD
Digoxin—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000192	0.00125	CcSEcCtD
Digoxin—Asthenia—Prednisone—systemic scleroderma	0.000191	0.00124	CcSEcCtD
Digoxin—Feeling abnormal—Methotrexate—systemic scleroderma	0.000183	0.00119	CcSEcCtD
Digoxin—Diarrhoea—Prednisone—systemic scleroderma	0.000182	0.00118	CcSEcCtD
Digoxin—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000182	0.00118	CcSEcCtD
Digoxin—Dizziness—Prednisone—systemic scleroderma	0.000176	0.00114	CcSEcCtD
Digoxin—Abdominal pain—Methotrexate—systemic scleroderma	0.000176	0.00114	CcSEcCtD
Digoxin—Vomiting—Prednisone—systemic scleroderma	0.000169	0.0011	CcSEcCtD
Digoxin—Rash—Prednisone—systemic scleroderma	0.000168	0.00109	CcSEcCtD
Digoxin—Dermatitis—Prednisone—systemic scleroderma	0.000168	0.00109	CcSEcCtD
Digoxin—Headache—Prednisone—systemic scleroderma	0.000167	0.00108	CcSEcCtD
Digoxin—Asthenia—Methotrexate—systemic scleroderma	0.000159	0.00104	CcSEcCtD
Digoxin—Nausea—Prednisone—systemic scleroderma	0.000158	0.00103	CcSEcCtD
Digoxin—Diarrhoea—Methotrexate—systemic scleroderma	0.000152	0.00099	CcSEcCtD
Digoxin—Dizziness—Methotrexate—systemic scleroderma	0.000147	0.000956	CcSEcCtD
Digoxin—Vomiting—Methotrexate—systemic scleroderma	0.000141	0.00092	CcSEcCtD
Digoxin—Rash—Methotrexate—systemic scleroderma	0.00014	0.000912	CcSEcCtD
Digoxin—Dermatitis—Methotrexate—systemic scleroderma	0.00014	0.000911	CcSEcCtD
Digoxin—Headache—Methotrexate—systemic scleroderma	0.000139	0.000906	CcSEcCtD
Digoxin—Nausea—Methotrexate—systemic scleroderma	0.000132	0.000859	CcSEcCtD
